Articolo in rivista, 2023, ENG, 10.1016/j.carbon.2023.118058
Papi M.; De Spirito M.; Palmieri V.
Fondazione Policlinico Universitario "A. Gemelli" IRCSS, Largo A. Gemelli, Rome, 8 00168, Italy; Dipartimento di Neuroscienze, Università Cattolica del Sacro Cuore, Largo Francesco Vito 1, Rome, 00168, Italy; Istituto dei Sistemi Complessi, CNR, Via dei Taurini 19, Rome, 00185, Italy
The Coronavirus Disease 2019 (COVID-19) pandemic has led to collaboration between nanotechnology scientists, industry stakeholders, and clinicians to develop solutions for diagnostics, prevention, and treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infections. Nanomaterials, including carbon-based materials (CBM) such as graphene and carbon nanotubes, have been studied for their potential in viral research. CBM unique effects on microorganisms, immune interaction, and sensitivity in diagnostics have made them a promising subject of SARS-CoV-2 research. This review discusses the interaction of CBM with SARS-CoV-2 and their applicability, including CBM physical and chemical properties, the known interactions between CBM and viral components, and the proposed prevention, treatment, and diagnostics uses.
Carbon 210 , pp. 118058-1–118058-19
SARS-CoV-2, Omicron, Graphene, Carbon, Antivirals, Nanomaterials, Nanotechnology
ID: 481468
Year: 2023
Type: Articolo in rivista
Creation: 2023-05-15 14:08:10.000
Last update: 2023-11-27 12:31:35.000
CNR authors
CNR institutes
External links
OAI-PMH: Dublin Core
OAI-PMH: Mods
OAI-PMH: RDF
DOI: 10.1016/j.carbon.2023.118058
URL: https://www.sciencedirect.com/science/article/pii/S0008622323002993
External IDs
CNR OAI-PMH: oai:it.cnr:prodotti:481468
DOI: 10.1016/j.carbon.2023.118058
Scopus: 2-s2.0-85156143376
ISI Web of Science (WOS): 001001548200001